KEGG   DISEASE: Schizophrenia
H01649                      Disease                                

Schizophrenia is a common serious psychotic illness that typically emerges in late adolescence and early adulthood. It is characterized by hallucinations and delusions (commonly known as positive symptoms), social withdrawal, alogia, and flat affect (negative symptoms), and cognitive disabilities. While treatments exist for the psychotic symptoms of schizophrenia, there is no effective therapy to prevent the cognitive impairments. The disorder is substantially heritable, but expression of the clinical phenotype is likely to involve the interplay of multiple susceptibility variants, epigenetic factors, and environmental influences. Although it has been suggested that many of the promising candidate genes are involved in the development and maintenance of synaptic function, the most of them remains to be identified. The pathogenic mechanisms underlying schizophrenia are unknown, but observers have repeatedly noted pathological features involving excessive loss of gray matter and reduced numbers of synaptic structures on neurons. Recently, it has been found that alleles of the C4 genes are associated with schizophrenia in proportion to their tendency to promote greater expression of C4A in the brain.
Mental and behavioural disorder
Human diseases [BR:br08402]
 Other diseases
  Mental and behavioural disorders
   H01649  Schizophrenia
Human diseases in ICD-11 classification [BR:br08403]
 06 Mental, behavioural or neurodevelopmental disorders
  Schizophrenia or other primary psychotic disorders
   6A20  Schizophrenia
    H01649  Schizophrenia
hsa04080  Neuroactive ligand-receptor interaction
hsa04728  Dopaminergic synapse
hsa04012  ErbB signaling pathway
MTHFR [HSA:4524] [KO:K25004]
CHI3L1 [HSA:1116] [KO:K17523]
DISC1 [HSA:27185] [KO:K16534]
DISC2 [HSA:27184]
SYN2 [HSA:6854] [KO:K19941]
DRD3 [HSA:1814] [KO:K04146]
RTN4R [HSA:65078] [KO:K16659]
DAOA [HSA:267012] [KO:K24397]
HTR2A [HSA:3356] [KO:K04157]
AKT1 [HSA:207] [KO:K04456]
C4A [HSA:720] [KO:K03989]
APOL2 [HSA:23780] [KO:K14480]
APOL4 [HSA:80832] [KO:K14480]
PRODH [HSA:5625] [KO:K00318]
NRG1 [HSA:3084] [KO:K05455]
Chlorpromazine hydrochloride [DR:D00789]
Fluphenazine decanoate [DR:D00793]
Perphenazine [DR:D00503]
Prochlorperazine maleate [DR:D00479]
Trifluoperazine hydrochloride [DR:D00799]
Thioridazine hydrochloride [DR:D00798]
Haloperidol decanoate [DR:D01898]
Haloperidol lactate [DR:D08035]
Molindone hydrochloride [DR:D00796]
Ziprasidone hydrochloride [DR:D01939]
Ziprasidone mesylate [DR:D02100]
Lurasidone hydrochloride [DR:D04820]
Thiothixene [DR:D00374]
Loxapine [DR:D02340]
Loxapine succinate [DR:D00794]
Clozapine [DR:D00283]
Olanzapine [DR:D00454]
Olanzapine pamoate [DR:D06623]
Quetiapine fumarate [DR:D00458]
Asenapine [DR:D11769]
Asenapine maleate [DR:D02995]
Risperidone [DR:D00426]
Aripiprazole [DR:D01164]
Aripiprazole lauroxil [DR:D10364]
Aripiprazole hydrate [DR:D10516]
Paliperidone [DR:D05339]
Paliperidone palmitate [DR:D05340]
Cariprazine hydrochloride [DR:D09876]
Brexpiprazole [DR:D10309]
Lumateperone tosylate [DR:D11170]
Olanzapine and samidorphan [DR:D12117]
Other DBs
ICD-11: 6A20
ICD-10: F20
MeSH: D012559
OMIM: 181500 600850 604906 603013
Austin J
Schizophrenia: an update and review.
J Genet Couns 14:329-40 (2005)
PMID:20718829 (gene, drug)
Cacabelos R, Martinez-Bouza R
Genomics and pharmacogenomics of schizophrenia.
CNS Neurosci Ther 17:541-65 (2011)
Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, Tooley K, Presumey J, Baum M, Van Doren V, Genovese G, Rose SA, Handsaker RE, Daly MJ, Carroll MC, Stevens B, McCarroll SA
Schizophrenia risk from complex variation of complement component 4.
Nature 530:177-83 (2016)
Mimmack ML, Ryan M, Baba H, Navarro-Ruiz J, Iritani S, Faull RL, McKenna PJ, Jones PB, Arai H, Starkey M, Emson PC, Bahn S
Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22.
Proc Natl Acad Sci U S A 99:4680-5 (2002)
Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, Semple CA, Devon RS, St Clair DM, Muir WJ, Blackwood DH, Porteous DJ
Disruption of two novel genes by a translocation co-segregating with schizophrenia.
Hum Mol Genet 9:1415-23 (2000)
Sinibaldi L, De Luca A, Bellacchio E, Conti E, Pasini A, Paloscia C, Spalletta G, Caltagirone C, Pizzuti A, Dallapiccola B
Mutations of the Nogo-66 receptor (RTN4R) gene in schizophrenia.
Hum Mutat 24:534-5 (2004)
Li T, Ma X, Sham PC, Sun X, Hu X, Wang Q, Meng H, Deng W, Liu X, Murray RM, Collier DA
Evidence for association between novel polymorphisms in the PRODH gene and schizophrenia in a Chinese population.
Am J Med Genet B Neuropsychiatr Genet 129B:13-5 (2004)
Thiselton DL, Webb BT, Neale BM, Ribble RC, O'Neill FA, Walsh D, Riley BP, Kendler KS
No evidence for linkage or association of neuregulin-1 (NRG1) with disease in the Irish study of high-density schizophrenia families (ISHDSF).
Mol Psychiatry 9:777-83; image 729 (2004)

» Japanese version

DBGET integrated database retrieval system